Exousia Bio, Inc.
LMMY - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$226.32K
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $226,324.00 |
|---|---|
| Enterprise Value | - |
| Earnings per Share | $0.01 |
| Beta | -8.88 |
| Outstanding Shares | 16,764,767 |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | -0.77 |
|---|---|
| PEG | 0.59 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Exousia Bio, Inc.
2 employees
CEO: Matthew Dwyer
Exousia Bio, Inc. is a biotechnology company that designs, develops, and manufactures mammalian- and plant-derived exosomes using proprietary technologies for nucleic acid loading and targeted delivery to tissues and cells. The company's...